Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Dianthus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DNTH.
You can purchase shares of Dianthus Therapeutics (NASDAQ:DNTH) through any online brokerage.
Other companies in Dianthus Therapeutics’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT) and Replimune Group (NASDAQ:REPL).
Dianthus Therapeutics has a consensus price target of $51.13.
The stock price for Dianthus Therapeutics (NASDAQ: DNTH) is $20.45 last updated April 21, 2025 at 4:01 PM EDT.
There are no upcoming dividends for Dianthus Therapeutics.
Dianthus Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Dianthus Therapeutics.
Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.